# 119-hr-9190: Right to Try for Individualized Treatments Act

119-hr-9190, Right to Try for Individualized Treatments Act, is a 119th Congress bill sponsored by Rep. Harshbarger, Diana [R-TN-1] (R-TN); status introduced; PRIA reads it as touching household money (as of 2026-07-23).

- Canonical: https://policyrisk.com/legislation/119-hr-9190
- As of: 2026-07-23
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 119-hr-9190
- Congress: 119
- Title: Right to Try for Individualized Treatments Act
- Status: introduced
- Introduced: 2026-06-08
- Sponsor: Rep. Harshbarger, Diana [R-TN-1] (R-TN)
- Cosponsors: 3
- Policy area: Health
- Touches household money: yes
- Last recorded action: 2026-07-23

## Summary

**Expands Right to Try to include investigational individualized medical treatments** for patients with life-threatening or severely debilitating conditions, setting eligibility, consent, and facility requirements. - Patients and families: Eligible patients could request access under two tracks that differ by eligibility and consent, with one track for investigational drugs and the other for individualized treatments for life-threatening or severely debilitating illness. - Physicians and health care facilities: Physicians must certify eligibility and be in good standing with their licensing boards and they may not accept direct manufacturer payment for that certification. Facilities must meet federal assurance requirements to offer these treatments. - Manufacturers: A manufacturer that complies with applicable federal assurance laws and operates within an eligible health care facility may offer investigational individualized medical treatments but is not required to do so. The law also extends statutory exemptions to cover these treatments.

## Cosponsors (3)

- Rep. Biggs, Andy [R-AZ-5] (R-AZ), 2026-06-08T00:00:00.000Z
- Rep. Gosar, Paul A. [R-AZ-9] (R-AZ), 2026-07-13T00:00:00.000Z
- Rep. Hamadeh, Abraham J. [R-AZ-8] (R-AZ), 2026-07-21T00:00:00.000Z

## Provisions PRIA read

- Access to individualized genomic treatments: benefit, medium. If enacted, this bill would let patients with life‑threatening or severely debilitating illnesses request experimental drugs or personalized genomic treatments. For the investigational drug path, you would need a life‑threatening diagnosis, exhausted approved options, inability to join a clinical t…

## Related bills

- 119-hr-2395: SHORT Act
- 119-hr-1181: Protecting Privacy in Purchases Act
- 119-hr-987: Fair Access to Banking Act
- 119-hr-1040: Senior Citizens Tax Elimination Act
- 119-hr-925: Dismantle DEI Act of 2025
- 119-hr-22: SAVE Act

## Sources
- [119-hr-9190 on Congress.gov](https://www.congress.gov/bill/119th-congress/house-bill/9190)

## Related
- [119-hr-2395: SHORT Act](https://policyrisk.com/legislation/119-hr-2395)
- [119-hr-1181: Protecting Privacy in Purchases Act](https://policyrisk.com/legislation/119-hr-1181)
- [119-hr-987: Fair Access to Banking Act](https://policyrisk.com/legislation/119-hr-987)
- [119-hr-1040: Senior Citizens Tax Elimination Act](https://policyrisk.com/legislation/119-hr-1040)
- [119-hr-925: Dismantle DEI Act of 2025](https://policyrisk.com/legislation/119-hr-925)
- [119-hr-22: SAVE Act](https://policyrisk.com/legislation/119-hr-22)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/119-hr-9190 (as of 2026-07-23).